ENOCHIAN BIOSCIENCES INC's ticker is ENOB and the CUSIP is 29350E104. A total of 35 filers reported holding ENOCHIAN BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,727 | -2.5% | 10,901 | -58.1% | 0.00% | – |
| Q2 2022 | $50,000 | -52.8% | 25,990 | +101.5% | 0.00% | -100.0% |
| Q1 2022 | $106,000 | -56.7% | 12,900 | -61.6% | 0.00% | -50.0% |
| Q4 2021 | $245,000 | +16.1% | 33,599 | +7.3% | 0.00% | -33.3% |
| Q3 2021 | $211,000 | – | 31,314 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,341,663 | $6,668,000 | 0.94% |
| Tibra Equities Europe Ltd | 41,900 | $208,000 | 0.06% |
| Virtu Financial LLC | 68,007 | $338,000 | 0.03% |
| Ergoteles LLC | 47,984 | $238,000 | 0.01% |
| Jacobi Capital Management LLC | 4,500 | $22,000 | 0.00% |
| HRT FINANCIAL LP | 41,058 | $204,000 | 0.00% |
| ETF MANAGERS GROUP, LLC | 14,099 | $72,000 | 0.00% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 47,691 | $237,000 | 0.00% |
| JANE STREET GROUP, LLC | 11,948 | $59,000 | 0.00% |
| UBS Group AG | 260 | $1,000 | 0.00% |